Get the Stockscreener App
115.79
0.24%
-0.28
After Hours:
115.57
-0.22
-0.19%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $115.79, with a volume of 12.80M.
It is down -0.24% in the last 24 hours and down -5.04% over the past month.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
See More
Previous Close:
$116.07
Open:
$115.155
24h Volume:
12.80M
Relative Volume:
0.97
Market Cap:
$286.28B
Revenue:
$64.93B
Net Income/Loss:
$18.26B
P/E Ratio:
15.92
EPS:
7.2751
Net Cash Flow:
$12.36B
1W Performance:
-6.49%
1M Performance:
-5.04%
6M Performance:
+36.69%
1Y Performance:
+23.18%
1-Day Range:
$113.82
$116.36
1-Week Range:
$113.82
$123.70
52-Week Range:
$73.31
$125.14
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, NVS, AZN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
115.79 | 286.97B | 64.93B | 18.26B | 12.36B | 7.2751 |
|
LLY
Lilly Eli Co
|
990.33 | 878.04B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
240.40 | 577.48B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
230.11 | 410.83B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
NVS
Novartis Ag Adr
|
160.12 | 307.23B | 54.72B | 14.02B | 15.32B | 7.1855 |
|
AZN
Astrazeneca Plc
|
194.22 | 306.31B | 58.80B | 10.24B | 8.98B | 3.2788 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-26 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-18-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Nov-24-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-13-25 | Initiated | Scotiabank | Sector Outperform |
| Oct-13-25 | Resumed | Citigroup | Neutral |
| Sep-17-25 | Downgrade | Berenberg | Buy → Hold |
| May-14-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-22-25 | Initiated | Cantor Fitzgerald | Neutral |
| Feb-18-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-10-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-08-25 | Downgrade | Truist | Buy → Hold |
| Dec-20-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Buy |
| Dec-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Merck & Co., Inc. $MRK Holdings Cut by LOM Asset Management Ltd - MarketBeat
Orion Porfolio Solutions LLC Has $9.65 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
GW&K Investment Management LLC Has $23.76 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Edgar Lomax Co. VA - MarketBeat
Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market - GlobeNewswire Inc.
Merck & Co., Inc. $MRK Shares Sold by Smith Chas P & Associates PA Cpas - MarketBeat
Merck & Co., Inc. $MRK Holdings Lifted by Dimensional Fund Advisors LP - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 1.4%Should You Sell? - MarketBeat
Merck & Co. Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
AI-Powered Tempus Inks New Multi-Year Merck DealTempus AI (NASDAQ:TEM) - Benzinga
Merck to collaborate with Tempus AI on precision oncology - Seeking Alpha
Victory Capital Management Inc. Has $397.27 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Oak Grove Capital LLC Sells 21,515 Shares of Merck & Co., Inc. $MRK - MarketBeat
Focus Partners Advisor Solutions LLC Grows Holdings in Merck & Co., Inc. $MRK - MarketBeat
Kahn Brothers Group Inc. Sells 56,715 Shares of Merck & Co., Inc. $MRK - MarketBeat
Laurel Wealth Advisors LLC Trims Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Down 1.9%Here's What Happened - MarketBeat
Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views? - Finviz
Merck & Co., Inc. $MRK Position Lifted by Kingsview Wealth Management LLC - MarketBeat
Elo Mutual Pension Insurance Co Has $24.19 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Company, Inc. (MRK) Stock Analysis: Healthcare Titan with Strong Buy Ratings and Growth Potential - DirectorsTalk Interviews
Fisher Asset Management LLC Sells 945,571 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck Scientists Launch Research Award to Support Rising Chemists of Color - CSRwire
Antibiotics Market - GlobeNewswire Inc.
Davis R M Inc. Lowers Stake in Merck & Co., Inc. $MRK - MarketBeat
Bahl & Gaynor Inc. Sells 1,406,091 Shares of Merck & Co., Inc. $MRK - MarketBeat
River Wealth Advisors LLC Boosts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Rafferty Asset Management LLC - MarketBeat
Quantbot Technologies LP Increases Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Bedell Frazier Investment Counselling LLC Sells 34,557 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Diversify Wealth Management LLC - MarketBeat
MRK SEC FilingsMerck & Co 10-K, 10-Q, 8-K Forms - Stock Titan
Merck & Co Inc says FDA sets PDUFA date of June 19, 2026 for Welireg and Keytruda - marketscreener.com
Merck & Co Inc Says FDA Sets PDUFA Date Of June 19, 2026 For Welireg And Keytruda - TradingView
Tounjian Advisory Partners LLC Sells 10,436 Shares of Merck & Co., Inc. $MRK - MarketBeat
TIAA Trust National Association Sells 16,354 Shares of Merck & Co., Inc. $MRK - MarketBeat
Harvest Portfolios Group Inc. Buys 57,528 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Erste Asset Management GmbH - MarketBeat
Artisan Partners Limited Partnership Increases Position in Merck & Co., Inc. $MRK - MarketBeat
Argent Trust Co Sells 39,601 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by American Century Companies Inc. - MarketBeat
Merck & Co. Inc. stock outperforms competitors on strong trading day - MarketWatch
A Look Into Merck & Co Inc's Price Over Earnings - Benzinga
Merck to lay off around 150 employees at US site amid slump in Gardasil sales - Reuters
Xponance Inc. Lowers Position in Merck & Co., Inc. $MRK - MarketBeat
Handelsbanken Fonder AB Sells 26,136 Shares of Merck & Co., Inc. $MRK - MarketBeat
Generali Investments Management Co LLC Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
FUKOKU MUTUAL LIFE INSURANCE Co Has $37.61 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Hohimer Wealth Management LLC Purchases 9,170 Shares of Merck & Co., Inc. $MRK - MarketBeat
Andra AP fonden Has $45.69 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
US Bancorp DE Lowers Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.67%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):